ARAY

Accuray Incorporated

Price

$0.19

return (12m)

-89.07%

p/e

-2.18

p/bv

2.57

DIVIDEND YIELD

0.00%

ARAY price

Accuray

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARAY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-22.10%

3 months

-26.70%

1 year

-89.07%

2 years

-89.43%

5 years

-95.08%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ARAY

Valuation

P/E

-2.18

Sector 1.07

Industry 3.44

P/BV

2.57

Sector 1.86

Industry 2.12

P/Revenue (PSR)

0.27

Sector 1.54

Industry 1.69

EV/EBITDA

29.64

Sector -45.27

Industry 1.81

EV/EBIT

29.64

Sector -48.49

Industry -3.96

P/EBITDA

-10.22

Sector -31.51

Industry -53.51

P/EBIT

-7.49

Sector -42.93

Industry -50.81

P/Total Assets

0.24

Sector 0.85

Industry 0.94

P/Net Current Assets

-0.94

Sector -25.71

Industry -10.60

P/Working Capital

1.11

Sector -4.14

Industry 2.66

EPS

-0.14

Sector -0.70

Industry -0.60

BVPS

0.11

Sector 4.52

Industry 4.74

Efficiency

Gross Margin

27.73%

Sector 49.51%

Industry 50.68%

EBITDA Margin

7.13%

Sector -280.81%

Industry -57.47%

EBIT Margin

-6.58%

Sector -19.82%

Industry -25.80%

Net Profit Margins

-12.24%

Sector -24.01%

Industry -29.17%

Asset Turnover

0.23

Sector 0.13

Industry 0.15

Profitability

ROE

-117.97%

Sector -23.78%

Industry -22.30%

ROA

-11.09%

Sector -24.20%

Industry -24.15%

ROIC

7.59%

Sector -584.46%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.50

Sector 1.91

Industry 1.98

Net Debt / EBITDA

14.71

Sector -23.21

Industry -2.21

Net Debt / EBIT

14.71

Sector -17.93

Industry -1.50

Net Debt / Equity

2.54

Sector -0.68

Industry -0.29

Gross Debt / Equity

3.51

Sector -0.72

Industry -0.82

Equity/Assets

0.09

Sector 0.46

Industry 0.47

Liabilities/Assets

0.91

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

-1.67%

Sector -

Industry -

5Y Earnings CAGR

31.88%

Sector -

Industry -

Fundamentals ARAY

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ARAY Accuray Incorporated	$0.19	-89.07%	0.00%	-2.18	2.57	-117.97%	-12.24%
ABT Abbott Laboratories	$102.20	-19.92%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.07	0.39%	3.28%	21.29	2.19	10.29%	13.93%
BSX Boston Scientific Corp.	$43.13	-54.80%	0.00%	17.05	2.51	14.73%	17.49%
TMDX TransMedics Group Inc.	$79.38	-26.01%	0.00%	18.01	5.27	29.28%	22.69%
RMD ResMed Inc.	$234.61	-12.84%	1.07%	21.81	5.05	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$521.27	-15.40%	0.00%	35.95	25.41	70.67%	25.03%
COHR Coherent Inc.	$283.44	155.12%	0.00%	74.48	5.34	7.16%	11.31%
SYK Stryker Corp.	$281.76	-21.68%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$24.82	-5.61%	4.20%	17.81	1.74	9.80%	6.30%
INMD InMode Ltd.	$14.33	-6.13%	0.00%	10.78	1.33	12.32%	20.69%
BDX Becton Dickinson and Company	$187.39	2.94%	2.30%	53.38	2.06	3.85%	6.29%
DXCM DexCom Inc.	$85.21	30.85%	0.00%	32.03	12.21	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.60	15.77%	0.00%	47.85	4.48	9.37%	15.43%
ALGN Align Technology Inc.	$141.41	12.41%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$27.86	-17.87%	2.88%	20.20	4.39	21.74%	9.20%
IRMD iRadimed Corporation	$89.76	26.66%	1.46%	48.20	10.92	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$92.30	-1.26%	1.08%	21.13	1.35	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARAY - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Accuray

Accuray Incorporated

Average Investor10 user rating

4.0 (3 people)

United States

36 years

Founded: 1990

2007

Time since IPO - 19 years

1.000

Employees

Accuray Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $107.37 million, with shareholders equity totaling $41.70 million.

The company employs approximately 1.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Accuray Incorporated reported $401.95 million in revenue, generating net income of $-49.19 million.

Key financial metrics include a P/E ratio of -2.18, a price-to-book (P/B) ratio of 2.57, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARAY.

Market cap

$107.37 million

Net worth

$41.70 million

$41,699,000.00

Assets

$443.68 million

$443,676,000.00

Total Shares Outstanding

363.37 million

363,365,000

Average Daily Trading Volume

$8.85 million

$8,854,044.56

Sector

Health

Industry

Medical Supplies and Equipment

ARAY

ARAY revenue and profits

Financial Results ARAY

DRAG THE FRAME TO SEE MORE DATA

ARAY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.73 16,27% (12M)

P/E

22.64

3.07%

ROE

6.12%

P/BV

1.39

CI - Cigna

$283.40 --1,90% (12M)

P/E

10.91

2.19%

ROE

16.04%

P/BV

1.75

CNC - Centene

$69.20 90,32% (12M)

P/E

-6.39

0.00%

ROE

-22.53%

P/BV

1.44

HUM - Humana

$424.68 59,34% (12M)

P/E

40.85

0.81%

ROE

6.63%

P/BV

2.71

SNY - Sanofi

$39.43 --16,02% (12M)

P/E

3.76

4.41%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$246.60 32,11% (12M)

P/E

29.77

2.03%

ROE

24.76%

P/BV

7.37

LLY - Eli Lilly

$1,168.32 43,48% (12M)

P/E

39.18

0.57%

ROE

78.84%

P/BV

30.89

HCA - HCA Healthcare

$460.26 12,61% (12M)

P/E

14.42

0.68%

ROE

-213.15%

P/BV

-30.74